{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:28:40Z","timestamp":1789986520130,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Infectious and immunological theories of schizophrenia have been discussed for over a century. Contradictory results for infectious agents in association with schizophrenia spectrum disorders (SSDs) were reported. The rationale of this study was to investigate intrathecal antibody synthesis of the most frequently discussed neurotropic pathogens using a pathogen-specific antibody index (AI) in patients with SSD in comparison to controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In 100 patients with SSD and 39 mentally healthy controls with idiopathic intracranial hypertension (IIH), antibodies against the herpesviruses EBV, CMV, and HSV 1\/2 as well as the protozoan Toxoplasma gondii, were measured in paired cerebrospinal fluid (CSF) and serum samples with ELISA-kits. From these antibody concentrations the pathogen-specific AIs were determined with the assumption of intrathecal antibody synthesis at values\u2009&gt;\u20091.5.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant difference was detected in the number of SSD patients with elevated pathogen-specific AI compared to the control group. In a subgroup analysis, a significantly higher EBV AI was observed in the group of patients with chronic SSD compared to patients with first-time SSD diagnosis (p\u2009=\u20090.003). In addition, two identified outlier EBV patients showed evidence for polyspecific immune reactions (with more than one increased AI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Evidence for the role of intrathecal EBV antibody synthesis was found in patients with chronic SSD compared to those first diagnosed. Apart from a possible infectious factor in SSD pathophysiology, the evidence for polyspecific immune response in outlier patients may also suggest the involvement of further immunological processes in a small subgroup of SSD patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12987-022-00355-7","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:18:12Z","timestamp":1659100692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders"],"prefix":"10.1186","volume":"19","author":[{"given":"Kimon","family":"Runge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd L.","family":"Fiebich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schlump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Dersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Tebartz van Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"355_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","volume":"91","author":"S Abrahamyan","year":"2020","unstructured":"Abrahamyan S, Ebersp\u00e4cher B, Hoshi M-M, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Gr\u00fcter T, Tackenberg B, Paul F, Then-Bergh F, K\u00fcmpfel T, Weber F, Stangel M, Bayas A, Wildemann B, Heesen C, Zettl U, Warnke C, Antony G, Hessler N, Wiendl H, Bittner S, Hemmer B, Gold R, Salmen A, Ruprecht K. Complete epstein-barr virus seropositivity in a large cohort of patients with early multiple sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:681\u20136. https:\/\/doi.org\/10.1136\/jnnp-2020-322941.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"355_CR2","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2009","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Arlington, VA: American Psychiatric Assoc; 2009.","edition":"4th ed"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.biopsych.2006.09.034","volume":"61","author":"GP Amminger","year":"2007","unstructured":"Amminger GP, McGorry PD, Berger GE, Wade D, Yung AR, Phillips LJ, Harrigan SM, Francey SM, Yolken RH. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiat. 2007;61:1215\u20137. https:\/\/doi.org\/10.1016\/j.biopsych.2006.09.034.","journal-title":"Biol Psychiat"},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.schres.2011.10.026","volume":"136","author":"I Arias","year":"2012","unstructured":"Arias I, Sorlozano A, Villegas E, Luna JdD, McKenney K, Cervilla J, Gutierrez B, Gutierrez J. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res. 2012;136:128\u201336. https:\/\/doi.org\/10.1016\/j.schres.2011.10.026.","journal-title":"Schizophr Res"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/7854_2019_93","volume":"44","author":"ME Benros","year":"2020","unstructured":"Benros ME, Mortensen PB. Role of infection, autoimmunity, atopic disorders, and the immune system in schizophrenia: evidence from epidemiological and genetic studies. Curr Top Behav Neurosci. 2020;44:141\u201359. https:\/\/doi.org\/10.1007\/7854_2019_93.","journal-title":"Curr Top Behav Neurosci"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A. Longitudinal analysis reveals high prevalence of epstein-barr virus associated with multiple sclerosis. Science. 2022;375:296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222.","journal-title":"Science"},{"key":"355_CR7","first-page":"132","volume":"28","author":"A Bolu","year":"2016","unstructured":"Bolu A, Oznur T, Tok D, Balikci A, Sener K, Celik C, Gulsun M. Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms. Psychiatr Danub. 2016;28:132\u20138.","journal-title":"Psychiatr Danub"},{"key":"355_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.schres.2018.11.002","volume":"206","author":"A Breier","year":"2019","unstructured":"Breier A, Buchanan RW, D\u2019Souza D, Nuechterlein K, Marder S, Dunn W, Preskorn S, Macaluso M, Wurfel B, Maguire G, Kakar R, Highum D, Hoffmeyer D, Coskinas E, Litman R, Vohs JL, Radnovich A, Francis MM, Metzler E, Visco A, Mehdiyoun N, Yang Z, Zhang Y, Yolken RH, Dickerson FB. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: results from the VISTA study. Schizophr Res. 2019;206:291\u20139. https:\/\/doi.org\/10.1016\/j.schres.2018.11.002.","journal-title":"Schizophr Res"},{"key":"355_CR9","unstructured":"2018. Das AMDP-System: Manual zur dokumentation psychiatrischer Befunde, 10th ed., korrigierte Auflage. Hogrefe, G\u00f6ttingen. ISBN: 9783844428858."},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.3390\/jcm9082391","volume":"9","author":"R Dersch","year":"2020","unstructured":"Dersch R, Tebartz van Elst L, Hochstuhl B, Fiebich BL, Stich O, Robinson T, Matysik M, Michel M, Runge K, Nickel K, Domschke K, Endres D. Anti-thyroid peroxidase and anti-thyroglobulin autoantibodies in the cerebrospinal fluid of patients with unipolar depression. J Clin Med. 2020;9:2391. https:\/\/doi.org\/10.3390\/jcm9082391.","journal-title":"J Clin Med"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/schbul\/sby164","volume":"45","author":"F Dickerson","year":"2019","unstructured":"Dickerson F, Jones-Brando L, Ford G, Genovese G, Stallings C, Origoni A, O\u2019Dushlaine C, Katsafanas E, Sweeney K, Khushalani S, Yolken R. Schizophrenia is associated with an aberrant immune response to epstein-barr virus. Schizophr Bull. 2019;45:1112\u20139. https:\/\/doi.org\/10.1093\/schbul\/sby164.","journal-title":"Schizophr Bull"},{"key":"355_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.schres.2020.12.018","volume":"228","author":"F Dickerson","year":"2021","unstructured":"Dickerson F, Katsafanas E, Origoni A, Squire A, Khushalani S, Newman T, Rowe K, Stallings C, Savage CLG, Sweeney K, Nguyen TT, Breier A, Goff D, Ford G, Jones-Brando L, Yolken R. Exposure to epstein barr virus and cognitive functioning in individuals with schizophrenia. Schizophr Res. 2021;228:193\u20137. https:\/\/doi.org\/10.1016\/j.schres.2020.12.018.","journal-title":"Schizophr Res"},{"key":"355_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113157","volume":"291","author":"F Dickerson","year":"2020","unstructured":"Dickerson F, Schroeder JR, Nimgaonkar V, Gold J, Yolken R. The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: a meta-analysis. Psychiatry Res. 2020;291: 113157. https:\/\/doi.org\/10.1016\/j.psychres.2020.113157.","journal-title":"Psychiatry Res"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12987-017-0082-1","volume":"14","author":"D Endres","year":"2017","unstructured":"Endres D, Huzly D, Dersch R, Stich O, Berger B, Schuchardt F, Perlov E, Venhoff N, Hellwig S, Fiebich BL, Erny D, Hottenrott T, Tebartz van Elst L. Do patients with schizophreniform and bipolar disorders show an intrathecal, polyspecific, antiviral immune response? a pilot study. Fluids Barriers CNS. 2017;14:34. https:\/\/doi.org\/10.1186\/s12987-017-0082-1.","journal-title":"Fluids Barriers CNS"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41398-020-00967-3","volume":"10","author":"D Endres","year":"2020","unstructured":"Endres D, Meixensberger S, Dersch R, Feige B, Stich O, Venhoff N, Matysik M, Maier SJ, Michel M, Runge K, Nickel K, Urbach H, Domschke K, Pr\u00fcss H, Tebartz van Elst L. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry. 2020;10:279. https:\/\/doi.org\/10.1038\/s41398-020-00967-3.","journal-title":"Transl Psychiatry"},{"key":"355_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090203","author":"J Flegr","year":"2014","unstructured":"Flegr J, Prandota J, Sovi\u010dkov\u00e1 M, Israili ZH. Toxoplasmosis\u2014a global threat correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0090203.","journal-title":"PLoS ONE"},{"key":"355_CR17","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/61435","author":"AJ Fuglewicz","year":"2017","unstructured":"Fuglewicz AJ, Piotrowski P, Stodolak A. Relationship between toxoplasmosis and schizophrenia: a review. Adv Clin Exp Med. 2017. https:\/\/doi.org\/10.17219\/acem\/61435.","journal-title":"Adv Clin Exp Med"},{"key":"355_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175279","volume":"12","author":"RM Gie\u00df","year":"2017","unstructured":"Gie\u00df RM, Pfuhl C, Behrens JR, Rasche L, Freitag E, Khalighy N, Otto C, Wuerfel J, Brandt AU, Hofmann J, Ebersp\u00e4cher B, Bellmann-Strobl J, Paul F, Ruprecht K. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis. PLoS ONE. 2017;12: e0175279. https:\/\/doi.org\/10.1371\/journal.pone.0175279.","journal-title":"PLoS ONE"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF01314836","volume":"67","author":"T Gotlieb-Stematsky","year":"1981","unstructured":"Gotlieb-Stematsky T, Zonis J, Arlazoroff A, Mozes T, Sigal M, Szekely AG. Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients. Adv Virol. 1981;67:333\u20139. https:\/\/doi.org\/10.1007\/BF01314836.","journal-title":"Adv Virol"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12987-015-0024-8","volume":"12","author":"T Hottenrott","year":"2015","unstructured":"Hottenrott T, Dersch R, Berger B, Rauer S, Eckenweiler M, Huzly D, Stich O. The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort. Fluids Barriers CNS. 2015;12:27. https:\/\/doi.org\/10.1186\/s12987-015-0024-8.","journal-title":"Fluids Barriers CNS"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00415-018-8779-x","volume":"265","author":"T Hottenrott","year":"2018","unstructured":"Hottenrott T, Schorb E, Fritsch K, Dersch R, Berger B, Huzly D, Rauer S, Tebartz van Elst L, Endres D, Stich O. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis. J Neurol. 2018;265:1106\u201314. https:\/\/doi.org\/10.1007\/s00415-018-8779-x.","journal-title":"J Neurol"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0920-9964(02)00357-2","volume":"62","author":"L Jones-Brando","year":"2003","unstructured":"Jones-Brando L. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62:237\u201344. https:\/\/doi.org\/10.1016\/s0920-9964(02)00357-2.","journal-title":"Schizophr Res"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2014.05.019","volume":"158","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB. Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study. Schizophr Res. 2014;158:19\u201324. https:\/\/doi.org\/10.1016\/j.schres.2014.05.019.","journal-title":"Schizophr Res"},{"key":"355_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S0033291712000736","volume":"43","author":"GM Khandaker","year":"2013","unstructured":"Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013;43:239\u201357. https:\/\/doi.org\/10.1017\/S0033291712000736.","journal-title":"Psychol Med"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1192\/bjp.147.2.145","volume":"147","author":"DJ King","year":"1985","unstructured":"King DJ, Cooper SJ, Earle JA, Martin SJ, McFerran NV, Wisdom GB. Serum and CSF antibody titres to seven common viruses in schizophrenic patients. Br J psychiatry. 1985;147:145\u20139. https:\/\/doi.org\/10.1192\/bjp.147.2.145.","journal-title":"Br J psychiatry"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.msard.2019.02.019","volume":"30","author":"J Kolcava","year":"2019","unstructured":"Kolcava J, Hulova M, Benesova Y, Bednarik J, Stourac P. The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings. Multiple Scler Relat Disord. 2019;30:187\u201391. https:\/\/doi.org\/10.1016\/j.msard.2019.02.019.","journal-title":"Multiple Scler Relat Disord"},{"key":"355_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2020.152196","volume":"102","author":"H Kuzior","year":"2020","unstructured":"Kuzior H, Fiebich BL, Yousif NM, Saliba SW, Ziegler C, Nickel K, Maier SJ, S\u00fc\u00df P, Runge K, Matysik M, Dersch R, Berger B, Robinson T, Venhoff N, Kessler F, Blank T, Domschke K, Tebartz van Elst L, Endres D. Increased IL-8 concentrations in the cerebrospinal fluid of patients with unipolar depression. Compr Psychiatry. 2020;102: 152196. https:\/\/doi.org\/10.1016\/j.comppsych.2020.152196.","journal-title":"Compr Psychiatry"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00406-004-0481-6","volume":"254","author":"FM Leweke","year":"2004","unstructured":"Leweke FM, Gerth CW, Koethe D, Klosterk\u00f6tter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4\u20138. https:\/\/doi.org\/10.1007\/s00406-004-0481-6.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1056\/NEJMra1808803","volume":"381","author":"SR Marder","year":"2019","unstructured":"Marder SR, Cannon TD. Schizophrenia. N Engl J Med. 2019;381:1753\u201361. https:\/\/doi.org\/10.1056\/NEJMra1808803.","journal-title":"N Engl J Med"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1471-2334-11-281","volume":"11","author":"T Martelius","year":"2011","unstructured":"Martelius T, Lappalainen M, Palom\u00e4ki M, Anttila V-J. Clinical characteristics of patients with epstein barr virus in cerebrospinal fluid. BMC Infect Dis. 2011;11:281. https:\/\/doi.org\/10.1186\/1471-2334-11-281.","journal-title":"BMC Infect Dis"},{"key":"355_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01423-6","author":"M Michel","year":"2021","unstructured":"Michel M, Fiebich BL, Kuzior H, Meixensberger S, Berger B, Maier S, Nickel K, Runge K, Denzel D, Pankratz B, Schiele MA, Domschke K, Tebartz van Elst L, Endres D. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression. Transl Psychiatry. 2021. https:\/\/doi.org\/10.1038\/s41398-021-01423-6.","journal-title":"Transl Psychiatry"},{"key":"355_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3233\/HAB-170325","volume":"26","author":"M Mohagheghi","year":"2018","unstructured":"Mohagheghi M, Eftekharian MM, Taheri M, Alikhani MY. Determining the IgM and IgG antibodies titer against HSV1, HSV2 and CMV in the serum of schizophrenia patients. Hum Antibodies. 2018;26:87\u201393. https:\/\/doi.org\/10.3233\/HAB-170325.","journal-title":"Hum Antibodies"},{"key":"355_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.schres.2010.06.010","volume":"122","author":"PB Mortensen","year":"2010","unstructured":"Mortensen PB, Pedersen CB, Hougaard DM, N\u00f8rgaard-Petersen B, Mors O, B\u00f8rglum AD, Yolken RH. A Danish national birth cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res. 2010;122:257\u201363. https:\/\/doi.org\/10.1016\/j.schres.2010.06.010.","journal-title":"Schizophr Res"},{"key":"355_CR34","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10143-020-01321-3","volume":"44","author":"MF de Oliveira","year":"2021","unstructured":"de Oliveira MF, Yamashita RHG, Boa Sorte AA, Rotta JM, Norremose KA, Teixeira MJ, Pinto FCG. Psychiatric symptoms are frequent in idiopathic intracranial hypertension patients. Neurosurg Rev. 2021;44:1183\u20139.","journal-title":"Neurosurg Rev"},{"key":"355_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","volume":"7","author":"TA Pollak","year":"2020","unstructured":"Pollak TA, Lennox BR, M\u00fcller S, Benros ME, Pr\u00fcss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiat. 2020;7:93\u2013108. https:\/\/doi.org\/10.1016\/S2215-0366(19)30290-1.","journal-title":"Lancet Psychiat"},{"key":"355_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5409\/wjcp.v3.i3.59","volume":"3","author":"J Prandota","year":"2014","unstructured":"Prandota J, Gryglas A, Fuglewicz A, Zes\u0142awska-Fale\u0144czyk A, Ujma-Czapska B, Szenborn L, Mierzwa J. Recurrent headaches may be caused by cerebral toxoplasmosis. World J Clin Pediatr. 2014;3:59\u201368. https:\/\/doi.org\/10.5409\/wjcp.v3.i3.59.","journal-title":"World J Clin Pediatr"},{"key":"355_CR37","unstructured":"R Core Team, 2021. R: A Language and environment for statistical computing. vienna, austria. https:\/\/www.R-project.org\/."},{"key":"355_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","volume":"184","author":"H Reiber","year":"2001","unstructured":"Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101\u201322. https:\/\/doi.org\/10.1016\/S0022-510X(00)00501-3.","journal-title":"J Neurol Sci"},{"key":"355_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.schres.2021.03.022","volume":"231","author":"K Runge","year":"2021","unstructured":"Runge K, Fiebich BL, Kuzior H, Saliba SW, Yousif NM, Meixensberger S, Nickel K, Denzel D, Schiele MA, Maier SJ, Berger B, Dersch R, Domschke K, Tebartz van Elst L, Endres D. An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders. Schizophr Res. 2021;231:205\u201313. https:\/\/doi.org\/10.1016\/j.schres.2021.03.022.","journal-title":"Schizophr Res"},{"key":"355_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/brainsci10060355","volume":"10","author":"K Runge","year":"2020","unstructured":"Runge K, Tebartz van Elst L, Maier S, Nickel K, Denzel D, Matysik M, Kuzior H, Robinson T, Blank T, Dersch R, Domschke K, Endres D. cerebrospinal fluid findings of 36 adult patients with autism spectrum disorder. Brain Sci. 2020;10:355. https:\/\/doi.org\/10.3390\/brainsci10060355.","journal-title":"Brain Sci"},{"key":"355_CR41","volume-title":"Handbook of psychiatric measures","author":"AJ Rush","year":"2000","unstructured":"Rush AJ. Handbook of psychiatric measures. 1st ed. Washington, DC: American Psychiatric Association; 2000.","edition":"1"},{"key":"355_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/nature13595","author":"S Ripke","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomic Consortium, Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, et al. Biological insights from 108 schizophrenia associated genetic loci. Nature. 2014. https:\/\/doi.org\/10.1038\/nature13595.","journal-title":"Nature"},{"key":"355_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.03.015","author":"MC Shamier","year":"2021","unstructured":"Shamier MC, Bogers S, Yusuf E, van Splunter M, ten Berge JCEM, Titulaer M, van Kampen JJA, GeurtsvanKessel CH. The role of antibody indexes in clinical virology. Clinical Microbiol Infect. 2021. https:\/\/doi.org\/10.1016\/j.cmi.2021.03.015.","journal-title":"Clinical Microbiol Infect"},{"key":"355_CR44","doi-asserted-by":"publisher","first-page":"e15764","DOI":"10.7759\/cureus.15764","volume":"13","author":"R Sherchan","year":"2021","unstructured":"Sherchan R, Shrestha J, Omotosho YB, Dyatlova N, Nepomuceno JS. Herpes Simplex Virus-2 Meningitis Masquerading as Pseudotumor Cerebri. Cureus. 2021;13:e15764. https:\/\/doi.org\/10.7759\/cureus.15764.","journal-title":"Cureus"},{"key":"355_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0006-3223(94)90615-7","volume":"36","author":"S Srikanth","year":"1994","unstructured":"Srikanth S, Ravi V, Poornima K, Shetty KT, Gangadhar BN, Janakiramaiah N. Viral antibodies in recent onset, nonorganic psychoses: correspondence with symptomatic severity. Biol Psychiat. 1994;36:517\u201321. https:\/\/doi.org\/10.1016\/0006-3223(94)90615-7.","journal-title":"Biol Psychiat"},{"key":"355_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219454","volume":"14","author":"EV Stepanova","year":"2019","unstructured":"Stepanova EV, Kondrashin AV, Sergiev VP, Morozova LF, Turbabina NA, Maksimova MS, Romanov DV, Kinkulkina MA, Lazareva AV, Morozov EN. Toxoplasmosis and mental disorders in the Russian Federation (with special reference to schizophrenia). PLoS ONE. 2019;14: e0219454. https:\/\/doi.org\/10.1371\/journal.pone.0219454.","journal-title":"PLoS ONE"},{"key":"355_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bdi.12244","volume":"17","author":"O Stich","year":"2015","unstructured":"Stich O, Andres TA, Gross CM, Gerber SI, Rauer S, Langosch JM. An observational study of inflammation in the central nervous system in patients with bipolar disorder. Bipolar Disord. 2015;17:291\u2013302. https:\/\/doi.org\/10.1111\/bdi.12244.","journal-title":"Bipolar Disord"},{"key":"355_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neures.2016.11.002","volume":"115","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Matsuda T, Hayes LN, Yang S, Rodriguez K, Severance EG, Yolken RH, Sawa A, Eaton WW. Infection and inflammation in schizophrenia and bipolar disorder. Neurosci Res. 2017;115:59\u201363. https:\/\/doi.org\/10.1016\/j.neures.2016.11.002.","journal-title":"Neurosci Res"},{"key":"355_CR49","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.17433\/978-3-17-031259-3","volume-title":"Vom Anfang und Ende der Schizophrenie: Eine neuropsychiatrische Perspektive auf das Schizophrenie-Konzept","author":"L Tebartz van Elst","year":"2017","unstructured":"Tebartz van Elst L. Vom Anfang und Ende der Schizophrenie: Eine neuropsychiatrische Perspektive auf das Schizophrenie-Konzept. Stuttgart: Kohlhammer Verlag; 2017. p. 1255."},{"key":"355_CR50","first-page":"211","volume":"49","author":"Y Tedla","year":"2011","unstructured":"Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A. Serum antibodies to toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J. 2011;49:211\u201320.","journal-title":"Ethiop Med J"},{"key":"355_CR51","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/schbul\/sbs043","volume":"38","author":"EF Torrey","year":"2012","unstructured":"Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012;38:642\u20137. https:\/\/doi.org\/10.1093\/schbul\/sbs043.","journal-title":"Schizophr Bull"},{"key":"355_CR52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00023210-200620110-00001","volume":"20","author":"EF Torrey","year":"2006","unstructured":"Torrey EF, Leweke MF, Schwarz MJ, Mueller N, Bachmann S, Schroeder J, Dickerson F, Yolken RH. Cytomegalovirus and schizophrenia. CNS Drugs. 2006;20:879\u201385. https:\/\/doi.org\/10.2165\/00023210-200620110-00001.","journal-title":"CNS Drugs"},{"key":"355_CR53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1192\/bjp.132.4.342","volume":"132","author":"EF Torrey","year":"1978","unstructured":"Torrey EF, Peterson MR, Brannon WL, Carpenter WT, Post RM, van Kammen DP. Immunoglobulins and viral antibodies in psychiatric patients. Br J psychiatry. 1978;132:342\u20138. https:\/\/doi.org\/10.1192\/bjp.132.4.342.","journal-title":"Br J psychiatry"},{"key":"355_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/science.6281883","author":"EF Torrey","year":"1982","unstructured":"Torrey EF, Yolken RH, Winfrey CJ. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science. 1982. https:\/\/doi.org\/10.1126\/science.6281883.","journal-title":"Science"},{"key":"355_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.schres.2019.01.001","volume":"209","author":"JD Tucker","year":"2019","unstructured":"Tucker JD, Bertke AS. Assessment of cognitive impairment in HSV-1 positive schizophrenia and bipolar patients: systematic review and meta-analysis. Schizophr Res. 2019;209:40\u20137. https:\/\/doi.org\/10.1016\/j.schres.2019.01.001.","journal-title":"Schizophr Res"},{"key":"355_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1212\/WNL.0b013e31823ed057","volume":"78","author":"JS Tzartos","year":"2012","unstructured":"Tzartos JS, Khan G, Vossenkamper A, Cruz-Sadaba M, Lonardi S, Sefia E, Meager A, Elia A, Middeldorp JM, Clemens M, Farrell PJ, Giovannoni G, Meier U-C. Association of innate immune activation with latent epstein-barr virus in active MS lesions. Neurology. 2012;78:15\u201323. https:\/\/doi.org\/10.1212\/WNL.0b013e31823ed057.","journal-title":"Neurology"},{"key":"355_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant graphics for data analysis. Cham: Springer; 2016. p. 260."},{"key":"355_CR58","doi-asserted-by":"publisher","first-page":"22551","DOI":"10.1038\/srep22551","volume":"6","author":"H Wilking","year":"2016","unstructured":"Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep. 2016;6:22551. https:\/\/doi.org\/10.1038\/srep22551.","journal-title":"Sci Rep"},{"key":"355_CR59","doi-asserted-by":"publisher","first-page":"15041","DOI":"10.1038\/npjschz.2015.41","volume":"1","author":"LD de Witte","year":"2015","unstructured":"de Witte LD, van Mierlo HC, Litjens M, Klein HC, Bahn S, Osterhaus AD. The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study. NPJ Schizophr. 2015;1:15041. https:\/\/doi.org\/10.1038\/npjschz.2015.41.","journal-title":"NPJ Schizophr"},{"key":"355_CR60","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/schbul\/sby082","volume":"44","author":"J Xiao","year":"2018","unstructured":"Xiao J, Prandovszky E, Kannan G, Pletnikov MV, Dickerson F, Severance EG, Yolken RH. Toxoplasma gondii: biological parameters of the connection to schizophrenia. Schizophr Bull. 2018;44:983\u201392. https:\/\/doi.org\/10.1093\/schbul\/sby082.","journal-title":"Schizophr Bull"},{"key":"355_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006040","volume":"11","author":"R Yolken","year":"2017","unstructured":"Yolken R, Torrey EF, Dickerson F. Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia. PLoS Negl Trop Dis. 2017;11: e0006040. https:\/\/doi.org\/10.1371\/journal.pntd.0006040.","journal-title":"PLoS Negl Trop Dis"},{"key":"355_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1128\/CMR.8.1.131","volume":"8","author":"RH Yolken","year":"1995","unstructured":"Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 1995;8:131\u201345. https:\/\/doi.org\/10.1128\/CMR.8.1.131.","journal-title":"Clin Microbiol Rev"},{"key":"355_CR63","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/mp.2008.5","volume":"13","author":"RH Yolken","year":"2008","unstructured":"Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? a review of the evidence. Mol Psychiat. 2008;13:470\u20139. https:\/\/doi.org\/10.1038\/mp.2008.5.","journal-title":"Mol Psychiat"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00355-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00355-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00355-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T03:45:18Z","timestamp":1700883918000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00355-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00355-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"21 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective analysis received approval from the local ethics committee of the University of Freiburg (EK Fr 609\/14). The patients gave their written informed consent before the lumbar puncture.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KR: None. AB: None. BLF: None. SJM: None. BP: None. AS: None. KN: None. RD: Lecture fees from Roche and Alexion, travel grants from Biogen. KD: Steering Committee Neurosciences, Janssen. LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics. DE: None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}